Return to top of page

Modelling the Value of Innovative Treatments For Alzheimer’s Disease in the United States

June 8, 2021   |   Alliance for Aging Research Team   |   Alzheimer's Disease, Care Innovation & Access

Alliance for Aging Research President and CEO Sue Peschin joined Dana Goldman, Charles Makin, and Peter Neumann to co-author “Modelling the Value of Innovative Treatments For Alzheimer’s Disease in the United States,” a study published in the Journal of Medical Economics. You can read the full study here.

Candid Seal of Platinum Transparency 2022

The Alliance for Aging Research is a proud recipient of Candid’s Platinum Seal of Transparency.

Charity Navigator logo

The Alliance for Aging Research is proud to be rated a 4-star charity by Charity Navigator.